Challenges and opportunities in animal drug development: A regulatory perspective

Nature Reviews Drug Discovery

Volumn 2, Issue 11, 2003, Pages 915-918

  Lathers, Claire M ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; CARPROFEN; CELECOXIB; DERACOXIB; GENERIC DRUG; IVERMECTIN; NONSTEROID ANTIINFLAMMATORY AGENT; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROFECOXIB; TEPOXALIN; UNCLASSIFIED DRUG; VANCOMYCIN; VETERINARY DRUG;

AGRICULTURAL MANAGEMENT; ANIMAL HEALTH; ANTIBIOTIC RESISTANCE; ARTHRITIS; ARTICLE; DATA ANALYSIS; DOG DISEASE; DOMESTIC ANIMAL; DRUG APPROVAL; DRUG CLASSIFICATION; DRUG LABELING; DRUG MECHANISM; DRUG MONITORING; DRUG QUALITY; DRUG RESEARCH; DRUG SAFETY; DRUG STRUCTURE; FOOD AND DRUG ADMINISTRATION; GOOD MANUFACTURING PRACTICE; INTERNATIONAL COOPERATION; NONHUMAN; PRIORITY JOURNAL; PRODUCTIVITY; RISK MANAGEMENT; VETERINARY MEDICINE;

EID: 0242521435     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd1229     Document Type: Article

References (27)

1. Wood Mackenzie. Animal Health Service (Wood Mackenzie, Edinburgh, 2002).
2. Evans, T. & Chapple, N. The animal health market. Nature Rev. Drug Discov. 1, 937-938 (2002).
3. CFR 510.3.
4. Title 21, Chapter 9, Subchapter V, Part A, Section 360b.
5. Animal Drug Availability Act [online] (cited 1 May 2002) http://www.fda.gov/cvm/index/adaa/adaa66.pdf (1996).
6. CVM Update [online] (cited 1 May 2002) http://www.fda.gov/cvm/index/updates/adaa.html (1996).
7. Animal Medicinal Drug Use Clarification Act [online] (cited 1 May 2002) http://www.fda.gov/cvm/index/amducca/amducatoc.htm (1994).
8. Federal Food, Drug, and Cosmetic Act (21U. S. C. 301 et seq.).
9. Federal Register 61, 57732-57746 (1996).
10. 21 CFR part 530.
11. Federal Register 62, 27944-27945 (1997).
12. Minor Use and Minor Species Animal Health Act [online] (cited 1 May 2002) http://www.fda.gov/cvm/index/mums/minortoc.htm (2001).
13. Generic Animal Drug Patent Term Restoration Act. [online] (cited 1 May 2002) http://www.fda.gov/cvm/index/adaa/adaa66.pdf (1996).
14. CVMM-50 [online] (cited 1 May 2002) http://www.fda.gov/cvm/index/memos/cvmm50.html (1992).
15. Martinez, M., Langston, C., Martin, T. & Conner, D. Challenges associated with the evaluation of veterinary product bioequivalence: an AAVPT perspective. J. Vet. Pharmacol. Ther. 25, 201-220 (2002).
16. FDA Veterinarian XVII, 1-2 (Sept/Oct 2002).
17. Teuber, M. Veterinary use and antibiotic resistance. Curr. Opin. Microbiol. 4, 493-499 (2001).
18. U.S. Food and Drug Administration. A proposed framework for evaluating and assuring the human safety of the microbial effects of antimicrobial new animal drugs intended for use in food-producing animals. Federal Register Jan 6 (1999).
19. FDA Guidance 152 'Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern' (2002).
20. Singer, R. S., Finch, R., Wegener, H. C. & Bywater, R. Antibiotic resistance - the interplay between antibiotic use in animals and human beings. People, animals, and antibiotic resistance forum. Lancet Infect. Dis. 3, 47-51 (2003).
21. To ban or not to ban? Lancet Infect. Dis. 3, 1 (2003).
22. Flower, R. J. The development of COX2 inhibitors. Nature Rev. Drug Discov. 2, 179-191 (2003).
23. Johnston, S. A. & Budsberg, S. C. Nonsteroidal anti-inflammatory drugs and corticosteroids for the management of canine osteoarthritis. Vet. Clin. North. Am. Small Anim. Pract. 27, 841-862 (1997).
24. Streppa, H. K., Jones, C. J. & Budsberg S. C. Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs in canine blood. Am. J. Vet. Res. 63, 91-94 (2002).
25. Ricketts, A. P. et al. Evaluation of selective inhibition of canine cyclooxygenase 1 and 2 by carprofen and other nonsteroidal anti-inflammatory drugs. Am. J. Vet. Res. 59, 1441-1446 (1998).
26. Gierse, J. K. et al. Cloning, expression, and selective inhibition of canine cyclooxygenase-1 and cyclooxygenase-2. Vet. Ther. 3, 270-280 (2002).
27. Martel-Pelletier, J., Lajeunesse, D., Reboul, P. & Pelletier, J. P. Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective nonsteroidal anti-inflammatory drugs. Ann. Rheum. Dis. 62, 501-509 (2003).